MRI techniques to monitor MS evolution: The present and the future

Massimo Filippi, Robert I. Grossman

Research output: Contribution to journalArticle

Abstract

Conventional MRI (cMRI) is limited in its ability to provide specific information about pathology in MS. Measures commonly derived from cMRI include T2 lesions, T1-enhanced lesions, atrophy, and possibly T1-hypointense lesions, which have been extensively investigated in many clinical trials. Better MRI measures are needed to advance our understanding of MS and design ideal clinical trials. This article reviews the strengths and weaknesses of the major MRI-based methods used to monitor MS evolution and submits that 1) metrics derived from magnetization transfer MRI, diffusion-weighted MRI, and proton MRS should be implemented to achieve reliable specific in vivo quantification of MS pathology; 2) targeted multiparametric MRI protocols rather than generic application of cMRI should be used in all possible clinical circumstances and trials; and 3) reproducible quantitative MR measures should ideally be used for the assessment of patients but are essential for clinical trials.

Original languageEnglish
Pages (from-to)1147-1153
Number of pages7
JournalNeurology
Volume58
Issue number8
Publication statusPublished - Apr 23 2002

Fingerprint

Clinical Trials
Pathology
Diffusion Magnetic Resonance Imaging
Atrophy
Protons

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

MRI techniques to monitor MS evolution : The present and the future. / Filippi, Massimo; Grossman, Robert I.

In: Neurology, Vol. 58, No. 8, 23.04.2002, p. 1147-1153.

Research output: Contribution to journalArticle

Filippi, M & Grossman, RI 2002, 'MRI techniques to monitor MS evolution: The present and the future', Neurology, vol. 58, no. 8, pp. 1147-1153.
Filippi, Massimo ; Grossman, Robert I. / MRI techniques to monitor MS evolution : The present and the future. In: Neurology. 2002 ; Vol. 58, No. 8. pp. 1147-1153.
@article{a32e3b40f69e441fb74ab13c040e2552,
title = "MRI techniques to monitor MS evolution: The present and the future",
abstract = "Conventional MRI (cMRI) is limited in its ability to provide specific information about pathology in MS. Measures commonly derived from cMRI include T2 lesions, T1-enhanced lesions, atrophy, and possibly T1-hypointense lesions, which have been extensively investigated in many clinical trials. Better MRI measures are needed to advance our understanding of MS and design ideal clinical trials. This article reviews the strengths and weaknesses of the major MRI-based methods used to monitor MS evolution and submits that 1) metrics derived from magnetization transfer MRI, diffusion-weighted MRI, and proton MRS should be implemented to achieve reliable specific in vivo quantification of MS pathology; 2) targeted multiparametric MRI protocols rather than generic application of cMRI should be used in all possible clinical circumstances and trials; and 3) reproducible quantitative MR measures should ideally be used for the assessment of patients but are essential for clinical trials.",
author = "Massimo Filippi and Grossman, {Robert I.}",
year = "2002",
month = "4",
day = "23",
language = "English",
volume = "58",
pages = "1147--1153",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "8",

}

TY - JOUR

T1 - MRI techniques to monitor MS evolution

T2 - The present and the future

AU - Filippi, Massimo

AU - Grossman, Robert I.

PY - 2002/4/23

Y1 - 2002/4/23

N2 - Conventional MRI (cMRI) is limited in its ability to provide specific information about pathology in MS. Measures commonly derived from cMRI include T2 lesions, T1-enhanced lesions, atrophy, and possibly T1-hypointense lesions, which have been extensively investigated in many clinical trials. Better MRI measures are needed to advance our understanding of MS and design ideal clinical trials. This article reviews the strengths and weaknesses of the major MRI-based methods used to monitor MS evolution and submits that 1) metrics derived from magnetization transfer MRI, diffusion-weighted MRI, and proton MRS should be implemented to achieve reliable specific in vivo quantification of MS pathology; 2) targeted multiparametric MRI protocols rather than generic application of cMRI should be used in all possible clinical circumstances and trials; and 3) reproducible quantitative MR measures should ideally be used for the assessment of patients but are essential for clinical trials.

AB - Conventional MRI (cMRI) is limited in its ability to provide specific information about pathology in MS. Measures commonly derived from cMRI include T2 lesions, T1-enhanced lesions, atrophy, and possibly T1-hypointense lesions, which have been extensively investigated in many clinical trials. Better MRI measures are needed to advance our understanding of MS and design ideal clinical trials. This article reviews the strengths and weaknesses of the major MRI-based methods used to monitor MS evolution and submits that 1) metrics derived from magnetization transfer MRI, diffusion-weighted MRI, and proton MRS should be implemented to achieve reliable specific in vivo quantification of MS pathology; 2) targeted multiparametric MRI protocols rather than generic application of cMRI should be used in all possible clinical circumstances and trials; and 3) reproducible quantitative MR measures should ideally be used for the assessment of patients but are essential for clinical trials.

UR - http://www.scopus.com/inward/record.url?scp=0037161249&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037161249&partnerID=8YFLogxK

M3 - Article

C2 - 11971079

AN - SCOPUS:0037161249

VL - 58

SP - 1147

EP - 1153

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 8

ER -